ANGEL WILLIAMS-KENT: Open Payments
NPI 1598219214 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 16 payments from 9 companies in 2025. Trend: 2023 $180 · 2024 $76 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $196 |
| Janssen Pharmaceuticals, Inc | 2 | $81 |
| E.R. Squibb & Sons, L.L.C. | 2 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Indivior Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
Products named: ABILIFY MAINTENA, COBENFY, REXULTI, SPRAVATO, CAPLYTA, INVEGA SUSTENNA, UZEDY, SUBLOCADE.
Industry payments across VA — which companies pay providers there.
